The pharmaceutical chemicals manufacturing company Supriya Lifescience IPO Open on 16 Dec 2021 and closes on 20 Dec 2021. The company is raising funds of ₹700 crores through this IPO. In which shares will be issued through ₹200 crores fresh equity issue and ₹500 crore offer for sale. According to the company’s DRHP, this Supriya Lifescience IPO has reserved a quota of 75% for QIB Qualified Institutional Buyers, 15% for NII Non-Institutional Investors, and 10% for RII Retail Individual Investors.
Supriya Lifescience IPO will raise the fund to use reduce its Company Debt, Corporate use, and the company’s general operations. The main focus of the company is on development and research, the company has grown very well for the last several years.
Supriya Lifescience Ltd is a company that manufactures pharmaceuticals ingredients (“APIs”). Which is constantly doing its development and research work. The company has 39 pharmaceutical APIs with products such as antihistamine, analgesic, anesthetic, vitamins, anti-asthma, and antiallergic. The company has been the largest exporter of Chlorpheniramine Malate and Ketamine. The company contributes 45–55% and 65–70% respectively to hydrochloride API exports. And it is one of the largest exporters of Salbutamol Sulfate from India.
Supriya Lifescience IPO Review :
■ Apply For Listing Gain and Long Term
Supriya Lifescience IPO Date & Price Band & Details :
| IPO Open : | 16 December 202 |
| IPO Close : | 20 December 2021 |
| IPO Size : | ₹700. Cr |
| Face Value : | ₹2 Rs. Equity Share |
| Price Band : | ₹265–₹274 Per Share |
| Listing On : | BSE, NSE |
| Issue Size : | ₹700. Cr |
| Fresh Issue : | ₹200. Cr |
| Offer For Sale : | ₹500. Cr |
Supriya Lifescience IPO Market Lot :
Supriya Lifescience IPO Minimum Market lot is 1 Lot with 54 shares with ₹14,796 Application amount. The retail investors can apply up to 13 lots with 702 Shares or ₹192,348 amounts.
| Minimum Lot Size : | 1 Lot |
| Minimum Share : | 54 Shares |
| Minimum Amount : | ₹14,796 |
| Maximum Lot Size : | 13 Lot |
| Maximum shares : | 702 Shares |
| Maximum Amount : | ₹192,348 |
Supriya Lifescience IPO Shares Offer :
A Total of 25,547,445 shares are to be bid for the public issue by Supriya Lifescience IPO with 72,99,270 for Fresh issue and 18,248,175 for offer for sale Shares.
| Category | Shares Offers | Amount |
| Fresh issue : | 72,99,270 | ₹200.00 Cr |
| Offer For Sale : | 18,248,175 | ₹500.00 Cr |
| Total : | 25,547,445 | ₹700.00 Cr |
Supriya Lifescience IPO Reservation :
Supriya Lifescience IPO Total Reservation of 25,547,445 shares are to be bid for the public issue by Supriya Lifescience IPO with 19,160,584 for QIB and 38,32,117 for NII 25,54,744 For RII & – Shares EMP.
| Category | Reservation | Shares | Amount |
| QIB : | 75% | 19,160,584 | ₹525.00 Cr |
| NII : | 15% | 38,32,117 | ₹105.00 Cr |
| RII : | 10% | 25,54,744 | ₹70.00 Cr |
| EMP : | – % | – | ₹ |
| Total : | 100% | 25,547,445 | ₹700.00 Cr |
Supriya Lifescience IPO EPS :
The Supriya Lifescience company’s EPS growth is decreasing every year, which is shown to you in the table here.
| Year | EPS Growth in (Rs.) |
| 2020-9M | ₹10.41 |
| 2020 | ₹10.03 |
| 2019 | ₹5.39 |
| 2018 | ₹1.19 |
Supriya Lifescience IPO Peer Comparison PE :
The Supriya Lifescience, According to DRHP of the company some company is listed whose PE Multiple is shown in this table.
| Sr. No. | Company | PE Ratio |
| 1. | Solara Active Pharma Sciences Limited | 44.29 |
| 2. | Neuland Laboratories Limited | 12.63 |
| 3. | Aarti Drugs Limited | 60.57 |
| 4. | Wanbury Limited | 26.90 |
| 5. | Divis Laboratories Limited | 51.85 |
Supriya Lifescience IPO Dates :
Supriya Lifescience IPO Date is 16 December and the close date is 20 December 2021. The allotment will be finalized on 23 December 2021 and the IPO may list on 28 December 2021.
| Open Date : | 16 December 2021 |
| Close Date : | 20 December 2021 |
| Allotment Date : | 23 December 2021 |
| Refund Date : | 24 December 2021 |
| Share Credit Date : | 27 December 2021 |
| Listing Date : | 28 December 2021 |
Supriya Lifescience IPO Form :
There are two ways to apply in Supriya Lifescience IPO. You can apply for Supriya Lifescience IPO through ASBA available in your bank account. You have to go to your online bank login and select Supriya Lifescience IPO in the Invest section and apply through your bank account. Another option is you can apply for Supriya Lifescience IPO through IPO form download through NSE and BSE. See the Supriya Lifescience IPO Form – Download the NSE Form and BSE Form IPO Form, fill it, and submit it to your bank or your broker.
Supriya Lifescience Company Financial Report (Cr) :
| Year | Revenue | Expense | P&L |
| 2021 | ₹25,993.50 | ₹23,694.00 | ₹1,520.73 |
| 2020 | ₹21,762.53 | ₹21,377.81 | ₹230.24 |
| 2019 | ₹21,591.22 | ₹21,037.06 | ₹851.33 |
About Supriya Lifescience Company
Our Company was incorporated as ‘Supriya Lifescience Limited’ pursuant to a certificate of incorporation dated March 26, 2008, issued by the Registrar of Companies, Maharashtra at Mumbai (“RoC”), upon the conversion of ‘M/s Supriya Chemicals’, a partnership firm, into a public limited company, in accordance with the provisions of Part IX of the Companies Act, 1956. Our Company commenced operations pursuant to a certificate for commencement of business dated April 1, 2008, issued by RoC.
We are one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of March 31, 2021, we have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and antiallergic. We have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively, of the API exports from India, between Fiscal 2017 and 2020. We were among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume.
- Europe, which contributed to 25.81% of revenue from operation for the nine-month period ended December 31, 2020.
- Latin America, which contributed 12.37% of revenue from operation for the nine-month period ended December 31, 2020.
- Asia (excluding India), which contributed to 24.19% of revenue from operation for the nine-month period ended December 31, 2020.
- North America (including Canada), which contributed to 6.16% of revenue from operation for the nine-month period ended December 31, 2020.
- India, which contributed to 23.63% of revenue from operation for the nine month period ended December 31, 2020.
Company Strenghts
Our core strength lies in identifying generic molecules (off-patent) in our existing therapeutic segments which fits into our existing chemistry and production infrastructure and our ability to develop the product and scale up production. In order to achieve the same, our marketing and research, and development teams work in tandem to estimate the potential market (in terms of volume) and cost of development, raw materials, and production. With our focus on products that are high on value and low on competition, we are well-positioned to derive relatively higher returns from our investments.
Company Promoters :
■ Satish Waman Wagh
Supriya Lifescience Board of Directors
| Name | Designation |
| Satish Waman Wagh | Chairman and Managing Director |
| Smita Satish Wagh | Whole-time Director |
| Saloni Satish Wagh | Whole-time Director |
| Shivani Satish Wagh | Whole-time Director |
| Balasahab Gulabrao Sawant | Whole-time Director |
| Kedar Shankar Karmarkar | Independent Director |
| Bhairav Manojbhai Chokshi | Independent Director |
| Dileep Kumar Jain | Additional Independent Director |
| Dinesh Navnitlal Modi | Additional Independent Director |
| Neelam Yashpal Arora | Additional Independent Director |
Quick Link :
■ DRHP Draft Prospectus
■ RHP Draft Prospectus
Supriya Lifescience IPO Lead Managers :
■ ICICI Securities Limited
■ Axis Capital Limited
Supriya Lifescience IPO Registrar :
Link Intime India Private Limited
C-101, 247 Park, 1
st Floor,
L.B.S. Marg, Vikhroli West
Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
E-mail: [email protected]
Website: www.linkintime.co.in
Note: Check Supriya Lifescience IPO allotment status Visit IPOBAZAR Allotment Page And Search Your Registrar IPO Allotment Link. Click Here
Company Address :
Supriya Lifescience Pvt Ltd
207/208, Udyog Bhavan,
Sonawala Road,
Goregaon (East),
Mumbai – 400 063
Tel: +91 22 40332727
Website: www.supriyalifescience.com
Supriya Lifescience IPO FAQs :
What is Supriya Lifescience IPO?
Supriya Lifescience IPO is Mainboard IPO. They are going to raise ₹700. Crores via IPO. The issue is priced at ₹265-₹274 per equity share. The IPO is to be listed on NSE, BSE.
When Supriya Lifescience IPO will open?
The IPO is to open on 16 Dec 2021 – 20 Dec 2021 for QIB, NII & RII.
What is Supriya Lifescience IPO Size?
Supriya Lifescience IPO size is ₹700 Crores.
What is the Fresh issue size of Supriya Lifescience IPO?
The Fresh issue size of Supriya Lifescience IPO ₹200 Cr.
What is the Offer For Sale size of Supriya Lifescience IPO?
The Offer For Sale size of Supriya Lifescience IPO ₹500 Cr.
What is Supriya Lifescience IPO Price Band?
Supriya Lifescience IPO Price Band is ₹265-₹274 Per share.
What is Supriya Lifescience IPO Minimum and Maximum Lot Size?
The minimum bid is 1 Lot, 54 Shares with ₹14,796 amount while the maximum bid is 13 Lot, 702 shares with ₹192,348.
What is Supriya Lifescience IPO Investors Portion?
The investors’ portion for QIB 75%, NII 15%, RII 10%.
What is Supriya Lifescience IPO Allotment Date?
Supriya Lifescience IPO allotment date is 23 December 2021.
What is Supriya Lifescience IPO Listing Date?
Supriya Lifescience IPO listing date is 28 December 2021. The IPO to list on NSE, BSE.
How to Apply the Supriya Lifescience IPO through Zerodha?
Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Supriya Lifescience IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Supriya Lifescience IPO through Upstox?
Log in to Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Supriya Lifescience IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Supriya Lifescience IPO through Groww?
Log in to Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Supriya Lifescience IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Supriya Lifescience IPO through Paytm Money?
Log in to the Paytm Money Website or app. Now you can see Invest is IPOs Section and Click on IPO. You will see the IPO Name “Supriya Lifescience IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
| Supriya Lifescience IPO GMP: Click Here Supriya Lifescience IPO Subscription: Click Here Supriya Lifescience IPO Allotment: Click Here Supriya Lifescience IPO Listing: Click Here |
All Supriya Lifescience IPO-related links are available here. If you want to know the details then click on Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.